Career Search
Explore opportunities with Novartis below.
Notice to applicants for US job openings. Learn More
Showing 2117 results
- Sort by Sort ascending
- Job Title Sort ascending
- Business
- Location
- Site
- Date Posted
| Job Title Sort ascending | Business | Location | Site | Date Posted |
|---|---|---|---|---|
| Director, Business Applications & AI Products Regular, Full time | General Management | USA | East Hanover | Jan 06, 2026 |
| Production Technician, Weekend Nights Regular, Full time | Production / Manufacturing | USA | Indianapolis | Jan 06, 2026 |
| Production Lead, Weekend Days Regular, Full time | Production / Manufacturing | USA | Indianapolis | Jan 06, 2026 |
| Production Lead, Weekend Nights Regular, Full time | Production / Manufacturing | USA | Indianapolis | Jan 06, 2026 |
| Portfolio Account Specialist, Oncology - VIC (Part-Time) Regular (Sales), Part time | General Management | Australia | Victoria (VIC) | Jan 06, 2026 |
| Portfolio Account Specialist, Oncology - SA/ Tasmania (Part-Time) Regular (Sales), Part time | General Management | Australia | South Australia (SA) | Jan 06, 2026 |
| Head, Corporate Comms Regular, Full time | Communications | Japan | Toranomon (NPKK Head Office) | Jan 06, 2026 |
| Clinical Development Medical Manager Regulär, Full time | Development | China +Alternative Locations | Shanghai (Shanghai) | Jan 05, 2026 |
| Senior Expert Science & Technology - Process Research & Development Regulär, Full time | Development | China | Changshu (Jiangsu Province) | Jan 05, 2026 |
| QC Analyst II Regulär, Full time | Quality | China | Changping County (Beijing) | Jan 05, 2026 |
Pagination
- ‹ Previous page
- 1
- …
- 183
- 184
- 185
- 186
- 187
- 188
- 189
- …
- 212
- › Next page
Adverse Event Reporting
We encourage using the following electronic reporting tool for reporting into the safety database directly: https://www.report.novartis.com/
If electronic reporting tool is not working – please use the following Generic mailbox: [email protected]
CISCO: +20 2 22861000: Press 3 for Adverse Event Reporting